Institutional investors purchased a net $5.2 million shares of EXAS during the quarter ended March 2017 and now own 92.71% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VOYA INVESTMENT MANAGEMENT CO. L... Bought 3.2 Million shares of Exact Sciences Corp
POINT72 ASSET MANAGEMENT LP Bought 2.3 Million shares of Exact Sciences Corp
MILLENNIUM MANAGEMENT LLC Bought 2.2 Million shares of Exact Sciences Corp